Lee's Pharmaceutical Holdings Ltd
HKEX:950
Lee's Pharmaceutical Holdings Ltd
Research & Development
Lee's Pharmaceutical Holdings Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lee's Pharmaceutical Holdings Ltd
HKEX:950
|
Research & Development
-HK$91.4m
|
CAGR 3-Years
28%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-9%
|
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Research & Development
-¥942.9m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-26%
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Research & Development
-¥5.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Research & Development
-HK$2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
H
|
HUTCHMED (China) Ltd
HKEX:13
|
Research & Development
-$188.8m
|
CAGR 3-Years
19%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-14%
|
|
Lee's Pharmaceutical Holdings Ltd
Glance View
Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacture and sale of pharmaceutical products. The firm operates through two segments. Proprietary Products segment is engaged in the manufacture and sales of self-developed pharmaceutical products. Its proprietary products include Yallaferon, Livaracine and Slounase, among others. Licensed-in Products segment is engaged in the trading of licensed-in pharmaceutical products. Its licensed-in products include Ferplex and Zanidip, among others. The Company’s products are for cardiovascular and infectious diseases, dermatology, oncology, gynecology and ophthalmology, among others. The firm mainly operates businesses in China and Hong Kong.
See Also
What is Lee's Pharmaceutical Holdings Ltd's Research & Development?
Research & Development
-91.4m
HKD
Based on the financial report for Jun 30, 2025, Lee's Pharmaceutical Holdings Ltd's Research & Development amounts to -91.4m HKD.
What is Lee's Pharmaceutical Holdings Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-9%
Over the last year, the Research & Development growth was -11%. The average annual Research & Development growth rates for Lee's Pharmaceutical Holdings Ltd have been 28% over the past three years , 9% over the past five years , and -9% over the past ten years .
